1-3 of 3
Luca Vaggelli
Close
Sort by
Journal Articles

Interim 18-FDG-PET/CT failed to predict the outcome in diffuse large B-cell lymphoma patients treated at the diagnosis with rituximab-CHOP

Clinical Trials & Observations
Patrizia Pregno, Annalisa Chiappella, Marilena Bellò, Barbara Botto, Simone Ferrero, Silvia Franceschetti, Francesca Giunta, Marco Ladetto, Giorgio Limerutti, Massimo Menga, Maura Nicolosi, Giorgio Priolo, Benedetta Puccini, Luigi Rigacci, Flavia Salvi, Luca Vaggelli, Roberto Passera, Gianni Bisi, Umberto Vitolo
Journal: Blood
Blood (2012) 119 (9): 2066–2073.
https://doi.org/10.1182/blood-2011-06-359943
Published: 2012
Journal Articles

The Outcome of Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with Rituximab-CHOP (R-CHOP) Is Not Predicted by 18-FDG-Positron Emission Tomography/Computerized Tomography (PET) Performed at Intermediate In-Course Evaluation, but Only by PET Assessed at the End of Therapy.

Umberto Vitolo, Annalisa Chiappella, Marilena Bellò, Roberto Passera, Barbara Botto, Giancarlo Castellano, Chiara Ciochetto, Simone Ferrero, Chiara Frairia, Silvia Franceschetti, Francesca Giunta, Marco Ladetto, Massimo Menga, Maura Nicolosi, Giorgio Priolo, Benedetta Puccini, Luigi Rigacci, Flavia Salvi, Luca Vaggelli, Patrizia Pregno, Gianni Bisi
Journal: Blood
Blood (2010) 116 (21): 2819.
https://doi.org/10.1182/blood.V116.21.2819.2819
Published: 2010
Journal Articles

Early Interim 18 f-FDG PET In Hodgkin's Lymphoma: Evaluation on 304 Patients

Pier Luigi Zinzani, MD, Luigi Rigacci, Vittorio Stefoni, Alessandro Broccoli, Benedetta Puccini, Letizia Gandolfi, Stefano Fanti, Antonio Castagnoli, Cinzia Pellegrini, Gian Carlo Montini, Federica Quirini, Giulia Antognoli, Luca Vaggelli, Enrico Derenzini, Lisa Argnani, Valentina Ambrosini, Claudio Agostinelli, Stefano A. Pileri, MD, Alberto Bosi, Michele Baccarani, MD
Journal: Blood
Blood (2010) 116 (21): 3879.
https://doi.org/10.1182/blood.V116.21.3879.3879
Published: 2010